Alcresta Therapeutics, Inc.

Alcresta Inc. Alcresta brings in $49.4m via Series C Alcresta Inc. (therapies for gastrointestinal disorders and rare diseases) raised $49.4m in its Series C financing to new backer Athyrium a

Alcresta Pharmaceuticals Inc. One Newton Executive Park Newton, MA 02462 Phone: +1 (617) 431-3600 Web Site: www.alcresta.com Contact: Robert Gallotto, President Industry Segment: Biotechnol

Start-Ups Across Health Care Alcresta Pharmaceuticals Inc. aims to combat malabsorption, with an initial focus on enzyme deficiencies, for people with gastrointestinal disorders and rare diseases.

Alcresta Pharmaceuticals Inc. One Newton Executive Park Newton, MA 02462 Phone: +1 (617) 431-3600 Web Site: www.alcresta.com Contact: Robert Gallotto, President Industry Segment: Biotechnol